Home
About Us
Pipeline
Partnerships
Investors
News & Events
Careers
| S*BIO Vision | Background | S*BIO Management | Board of Directors | Scientific Advisory Board | Corporate Values |
| Clinical Trials | Technologies & Capabilities |
| News & Press Releases | Participation in Events | Publications |
| Join Our Team | Career Opportunities |
 |
 |
|
The best scientist is open to experience and begins with romance - the idea that anything is possible. Ray Bradbury |
|
|
|
2004 Publications Drug Development Research December 2004; 62(4): 349 – 361 PLK1 as a potential drug target in cancer therapy Kee Chuan Goh, Haishan Wang, Niefang Yu, Yifa Zhou, Yin Zheng, Zeyi Lim, Kanda Sangthongpitag, Lijuan Fang, Mark X. Du, Xukun Wang, A. B. Jefferson, Janet Rose, Blanche Shamoon, Christoph Reinhard, Brad Carte, Michael Entzeroth, BinHui Ni, Marcia L. Taylor and Walter Stuenkel Drug Development Research December 2004; 62(4): 293 – 294 Research and development activities within Singapore's biomedical science initiative Michael Entzeroth Journal of Biomolecular Screening August 2004; 9(5): 427 – 433 Identification of novel small-molecule inhibitors for human transketolase by high-throughput screening with fluorescent intensity (FLINT) assay Mark X. Du, Janet Sim, Lijuan Fang, Yin Zheng, Sean Koh, Jennifer Stratton, Jaume Pons, John Jian-Xin Wang and Brat Carte
|
